A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls
出版年份 2013 全文链接
标题
A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls
作者
关键词
Antibodies, Vaccines, HPV-16, HPV-31, Antibody response, Vaccination and immunization, Human papillomavirus, Secretion
出版物
PLoS One
Volume 8, Issue 5, Pages e61825
出版商
Public Library of Science (PLoS)
发表日期
2013-05-02
DOI
10.1371/journal.pone.0061825
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance Serology
- (2012) Sara L. Bissett et al. Clinical and Vaccine Immunology
- Understanding and learning from the success of prophylactic human papillomavirus vaccines
- (2012) John T. Schiller et al. NATURE REVIEWS MICROBIOLOGY
- Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers
- (2012) Zhiming Huo et al. PLoS One
- Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation
- (2012) Rebecca Howell-Jones et al. VACCINE
- Worldwide burden of cervical cancer in 2008
- (2011) M. Arbyn et al. ANNALS OF ONCOLOGY
- Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
- (2011) Beibei Lu et al. BMC INFECTIOUS DISEASES
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human Papillomavirus 16 (HPV 16) and HPV 18 Antibody Responses Measured by Pseudovirus Neutralization and Competitive Luminex Assays in a Two- versus Three-Dose HPV Vaccine Trial
- (2011) Mel Krajden et al. Clinical and Vaccine Immunology
- Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
- (2011) Tino F. Schwarz et al. Human vaccines & immunotherapeutics
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay
- (2011) Darron R. Brown et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
- (2011) S. Longet et al. JOURNAL OF VIROLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Prevalence of Human Papillomavirus Antibodies in Males and Females in England
- (2011) Sarika Desai et al. SEXUALLY TRANSMITTED DISEASES
- Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
- (2011) Eve Draper et al. VACCINE
- HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
- (2011) Troy J. Kemp et al. VACCINE
- Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
- (2010) R Howell-Jones et al. BRITISH JOURNAL OF CANCER
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- (2010) Patricia M. Day et al. Cell Host & Microbe
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Potential mechanisms for HPV vaccine-induced long-term protection
- (2010) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
- (2009) John T. Schiller et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix???]
- (2008) Susan J Keam et al. DRUGS
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
- (2008) Troy J. Kemp et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started